SCHEMBL27228985

SCHEMBL27228985

CC1(C)OB(c2ccn3nc(NC(=O)[C@H]4C[C@@H]4c4ccccc4)cc3c2)OC1(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DEGS1 O15121 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HTT P42858 2/20 0.40
NAMPT P43490 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
ABL1 P00519 2/20 0.39
MAP4K4 O95819 1/20 0.39
MAPK8 P45983 1/20 0.39
CSNK1A1 P48729 1/20 0.39
CDK7 P50613 1/20 0.39
TYRO3 Q06418 1/20 0.39
LRRK2 Q5S007 1/20 0.39
AURKB Q96GD4 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
ROCK2 O75116 2/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24284598 0.85 MAP4K1 (0.48) ABL1MAP4K4MAPK8CSNK1A1CDK7
SCHEMBL26906310 0.83 SIK1 (0.41) ABL1MAP4K4MAPK8CSNK1A1CDK7
SCHEMBL26906352 0.81 MAP4K4 (0.41) ABL1MAP4K4MAPK8CSNK1A1CDK7
SCHEMBL24305581 0.75 MAP4K4 (0.38) ABL1MAP4K4MAPK8CSNK1A1CDK7
SCHEMBL26906155 0.73 PRMT5 (0.43) ABL1MAP4K4MAPK8CSNK1A1CDK7
SCHEMBL25200891 0.69 IRAK4 (0.39)
SCHEMBL22264948 0.68 FFAR1 (0.41) SMN1; SMN2ALDH1A1NPC1RAB9ATDP1
SCHEMBL22264949 0.68 FFAR1 (0.41) SMN1; SMN2ALDH1A1NPC1RAB9ATDP1
SCHEMBL17548446 0.65 P4HB (0.50) SMN1; SMN2ALDH1A1HTTNPC1RAB9A
SCHEMBL4715906 0.65 FFAR1 (0.48) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174662-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES CILAG AG (CH) 2024-05-30 US disclosed
EP-4284802-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES Janssen Biotech, Inc. (US) 2023-12-06 EP disclosed
WO-2022165530-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES JANSSEN BIOTECH, INC. (US) 2022-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174662-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES SIK2, SIK1, SGK2 DEGS1 2571/4885SMN1; SMN2 3406/4885ALDH1A1 4411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.